Role of the extracellular and intracellular loops of follicle-stimulating hormone receptor in its function

Frontiers in Endocrinology

Volumn 6, Issue JUL, 2015, Pages

  Banerjee, Antara A ^a   Mahale, Smita D ^a,b  

^a NATIONAL INSTITUTE FOR RESEARCH IN REPRODUCTIVE HEALTH   (India)

^b Genetic Research Centre India   (India)

Author keywords

C tail; Extracellular loops; FSH receptor; Intracellular loops; Receptor function

Indexed keywords

FOLLITROPIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; THYROTROPIN RECEPTOR;

CONFOCAL MICROSCOPY; GENE MUTATION; GLYCOSYLATION; HORMONE RECEPTOR INTERACTION; HUMAN; MUTAGENESIS; OVARY HYPERSTIMULATION; PALMITOYLATION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION;

EID: 84938906553     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2015.00110     Document Type: Review

References (82)

1. Fredriksson R, Lagerström MC, Lundin LG, Schiöth HB. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogongroups, and fingerprints. Mol Pharmacol (2003) 6:1256-72. doi: 10.1124/mol.63.6.1256.
2. Karnik SS, Gogonea C, Patil S, Saad Y, Takezako T. Activation of G-protein-coupled receptors: a common molecular mechanism. Trends Endocrinol Metab (2003) 14:431-7. doi:10.1016/j.tem.2003.09.007.
3. Vassart G, Pardo L, Costagliola S. A molecular dissection of the glycoprotein hormone receptors. Trends Biochem Sci (2004) 29:119-26. doi:10.1016/j.tibs.2004.01.006.
4. Hsu SY, Kudo M, Chen T, Nakabayashi K, Bhalla A, van der Spek PJ, et al. The three subfamilies of leucine-rich repeat-containing G protein-coupled receptors (LGR): identification of LGR6 and LGR7 and the signaling mechanism for LGR7. Mol Endocrinol (2000) 14:1257-71. doi:10.1210/mend.14.8.0510.
5. Bathgate RA, Halls ML, van der Westhuizen ET, Callander GE, Kocan M, Summers RJ. Relaxin family peptides and their receptors. Physiol Rev (2013) 93:405-80. doi:10.1152/physrev.00001.2012.
6. Pierce JG, Parsons TF. Glycoprotein hormones: structure and function. Annu Rev Biochem (1981) 50:465-95. doi:10.1146/annurev.bi.50.070181.002341.
7. Robker RL, Richards JS. Hormonal control of the cell cycle in ovarian cells: proliferation versus differentiation. Biol Reprod (1998) 59:476-82. doi:10.1095/biolreprod59.3.476.
8. Foulkes NS, Schlotter F, Pevet P, Sassone-Corsi P. Pituitary hormone FSH directs the CREM functional switch during spermatogenesis. Nature (1993) 362:264-7. doi:10.1038/362264a0.
9. Ulloa-Aguirre A, Conn PM. Targeting of G protein-coupled receptors to the plasma membrane in health and disease. Front Biosci (Landmark Ed) (2009) 14:973-94. doi:10.2741/3290.
10. Abell A, Liu X, Segaloff DL. Deletions of portions of the extracellular loops of the lutropin/choriogonadotropin receptor decrease the binding affinity for ovine luteinizing hormone, but not human choriogonadotropin, by preventing the formation of mature cell surface receptor. J Biol Chem (1996) 271:4518-27. doi:10.1074/jbc.271.8.4518.
11. Jiang X, Liu H, Chen X, Chen PH, Fischer D, Sriraman V, et al. Structure of follicle-stimulating hormone in complex with the entire ectodomain of its receptor. Proc Natl Acad Sci U S A (2012) 109:12491-6. doi:10.1073/pnas.1206643109.
12. Ji I, Lee C, Jeoung M, Koo Y, Sievert GA, Ji TH. Trans-activation of mutant follicle-stimulating hormone receptors selectively generates only one of two hormone signals. Mol Endocrinol (2004) 18:968-78. doi:10.1210/me.2003-0443.
13. Kleinau G, Jaeschke H, Mueller S, Raaka BM, Neumann S, Paschke R, et al. Evidence for cooperative signal triggering at the extracellular loops of the TSH receptor. FASEB J (2008) 22:2798-808. doi:10.1096/fj.07-104711.
14. Gonzalez-Robayna IJ, Falender AE, Ochsner S, Firestone GL, Richards JS. FSH stimulates phosphorylation and activation of protein kinase B (PKB/Akt) and serum and glucocorticoid-induced kinase (Sgk): evidence for A kinase-independent signaling in granulosa cells. Mol Endocrinol (2000) 14:1283-300. doi:10.1210/mend.14.8.0500.
15. Maizels ET, Cottom J, Jones JCR, Hunzicker-Dunn M. Follicle stimulating hormone (FSH) activates the p38 mitogen-activated protein kinase pathway, inducing small heat shock protein phosphorylation and cell rounding in immature rat ovarian granulosa cells. Endocrinology (1998) 139:3353-6. doi:10.1210/endo.139.7.6188.
16. Cottom J, Salvador LM, Maizels ET, Reierstad S, Park Y, Carr DW, et al. Follicle stimulating hormone activates extracellular signal-regulated kinase but not extracellular signal-regulated kinase kinase through a 100-kDa phosphotyrosine phosphatase. J Biol Chem (2003) 278:7167-79. doi:10.1074/jbc.M203901200.
17. Quintana J, Hipkin RW, Sanchez- Yague J, Ascoli M. Follitropin (FSH) and a phorbol ester stimulate the phosphorylation of the FSH receptor in intact cells. J Biol Chem (1994) 269:8772-9. doi:10.1210/jbc.Fedrrv.2.5.0409.
18. Krishnamurthy H, Kishi H, Shi M, Galet C, Bhaskaran RS, Hirakawa T, et al. Postendocytotic trafficking of the follicle-stimulating hormone (FSH)-FSH receptor complex. Mol Endocrinol (2003) 17:2162-76. doi:10.1210/me.2003-0118.
19. Ji I, Ji TH. Differential roles of exoloop 1 of the human follicle-stimulating hormone receptor in hormone binding and receptor activation. J Biol Chem (1995) 270:15970-3. doi:10.1074/jbc.270.27.15970.
20. Casas-González P, Scaglia HE, Pérez-Solís MA, Durand G, Scaglia J, Zariñán T, et al. Normal testicular function without detectable follicle-stimulating hormone. A novel mutation in the follicle-stimulating hormone receptor gene leading to apparent constitutive activity and impaired agonist-induced desensitization and internalization. Mol Cell Endocrinol (2012) 364:71-82. doi:10.1016/j.mce.2012.08.011.
21. Jaeschke H, Neumann S, Kleinau G, Mueller S, Claus M, Krause G, et al. An aromatic environment in the vicinity of serine 281 is a structural requirement for thyrotropin receptor function. Endocrinology (2006) 147:1753-60. doi:10.1210/en.2005-1138.
22. Dupakuntla M, Mahale SD. Accessibility of the extracellular loops of follicle stimulating hormone receptor and their role in hormone-receptor interaction. Mol Cell Endocrinol (2010) 315:131-7. doi:10.1016/j.mce.2009.10.002.
23. Nishi S, Nakabayashi K, Kobilka B, Hsueh AJ. The ectodomain of the luteinizing hormone receptor interacts with exoloop 2 to constrain the transmembrane region: studies using chimeric human and fly receptors. J Biol Chem (2002) 277:3958-64. doi:10.1074/jbc.M109617200.
24. Meduri G, Touraine P, Beau I, Lahuna O, Desroches A, Vacher-Lavenu MC, et al. Delayed puberty and primary amenorrhea associated with a novel mutation of the human follicle-stimulating hormone receptor: clinical, histological, and molecular studies. J Clin Endocrinol Metab (2003) 88:3491-8. doi:10.1210/jc.2003-030217.
25. Ludwig M, Gembruch U, Bauer O, Diedrich K. Ovarian hyperstimulation syndrome (OHSS) in a spontaneous pregnancy with fetal and placental triploidy: information about the general pathophysiology of OHSS. Hum Reprod (1998) 13:2082-7. doi:10.1093/humrep/13.8.2082.
26. Nappi RG, Di Nero E, D'Aries AP, Nappi L. Natural pregnancy in hypothyroid woman complicated by spontaneous ovarian hyperstimulation syndrome. Am J Obstet Gynecol (1998) 178:610-1. doi:10.1016/S0002-9378(98)70448-X.
27. Uchida S, Uchida H, Maruyama T, Kajitani T, Oda H, Miyazaki K, et al. Molecular analysis of a mutated FSH receptor detected in a patient with spontaneous ovarian hyper stimulation syndrome. PLoS One (2013) 8:e75478. doi:10.1371/journal.pone.0075478.
28. Delbaere A, Smits G, Olatunbosun O, Pierson R, Vassart G, Costagliola S. New insights into the pathophysiology of ovarian hyperstimulation syndrome. What makes the difference between spontaneous and iatrogenic syndrome? Hum Reprod (2004) 19:486-9. doi:10.1093/humrep/deh124.
29. Desai SS, Achrekar SK, Sahasrabuddhe KA, Meharji PK, Desai SK, Mangoli VS, et al. Functional characterization of two naturally occurring mutations (val(514)ala and ala(575)val) in follicle-stimulating hormone receptor. J Clin Endocrinol Metab (2015) 100:E638-45. doi:10.1210/jc.2014-3662.
30. Dupakuntla M, Pathak B, Roy BS, Mahale SD. Extracellular loop 2 in the FSH receptor is crucial for ligand mediated receptor activation. Mol Cell Endocrinol (2012) 362:60-8. doi:10.1016/j.mce.2012.05.008.
31. Banerjee AA, Dupakuntla M, Pathak BR, Mahale S. FSH receptor specific residues L501 and I505 in extracellular loop 2 are essential for its function. J Mol Endocrinol (2015) 54:193-204. doi:10.1530/JME-14-0275.
32. Li S, Liu X, Min L, Ascoli M. Mutations of the second extracellular loop of the human lutropin receptor emphasize the importance of receptor activation and de-emphasize the importance of receptor phosphorylation in agonist-induced internalization. J Biol Chem (2001) 276:7968-73. doi:10.1074/jbc.M010482200.
33. Touraine P, Beau I, Gougeon A, Meduri G, Desroches A, Pichard C, et al. New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype. Mol Endocrinol (1999) 13:1844-54. doi:10.1210/mend.13.11.0370.
34. Ryu K, Gilchrist RL, Tung CS, Ji I, Ji TH. High affinity hormone binding to the extracellular N-terminal exodomain of the follicle-stimulating hormone receptor is critically modulated by exoloop 3. J Biol Chem (1998) 273:28953-8. doi:10.1074/jbc.273.44.28953.
35. Sohn J, Ryu K, Sievert G, Jeoung M, Ji I, Ji TH. Follicle-stimulating hormone interacts with exoloop 3 of the receptor. J Biol Chem (2002) 277:50165-75. doi:10.1074/jbc.M207646200.
36. Sohn J, Youn H, Jeoung M, Koo Y, Yi C, Ji I, et al. Orientation of follicle-stimulating hormone (FSH) subunits complexed with the fsh receptor. J Biol Chem (2003) 278:47868-76. doi:10.1074/jbc.M307751200.
37. Claus M, Jaeschke H, Kleinau G, Neumann S, Krause G, Paschke R. A hydrophobic cluster in the center of the third extracellular loop is important for thyrotropin receptor signaling. Endocrinology (2005) 146:5197-203. doi:10.1210/en.2005-0713.
38. Lazari MF, Liu X, Nakamura K, Benovic JL, Ascoli M. Role of G protein-coupled receptor kinases on the agonist-induced phosphorylation and internalization of the follitropinreceptor. Mol Endocrinol (1999) 13:866-78. doi:10.1210/mend.13.6.0289.
39. Lefkowitz RJ. G protein-coupled receptors. III. New roles for receptor kinases and ß-arrestins in receptor signaling and desensitization. J Biol Chem (1998) 273:18677-80. doi:10.1074/jbc.273.30.18677.
40. Nakamura K, Hipkin RW, Ascoli M. The agonist-induced phosphorylation of the rat follitropin receptor maps to the first and third intracellular loops. Mol Endocrinol (1998) 12:580-91. doi:10.1210/mend.12.4.0087.
41. Krishnamurthy H, Galet C, Ascoli M. The association of arrestin-3 with the follitropin receptor depends on receptor activation and phosphorylation. Mol Cell Endocrinol (2003) 204:127-40. doi:10.1016/S0303-7207(03)00088-1.
42. Nechamen CA, Thomas RM, Cohen BD, Acevedo G, Poulikakos PI, Testa JR, et al. Human follicle-stimulating hormone (FSH) receptor interacts with the adaptor protein APPL1 in HEK 293 cells: potential involvement of the PI3K pathway in FSH signaling. Biol Reprod (2004) 71:629-36. doi:10.1095/biolreprod.103.025833.
43. Thomas RM, Nechamen CA, Mazurkiewicz JE, Ulloa-Aguirre A, Dias JA. The adapter protein APPL1 links FSH receptor to inositol 1,4,5-trisphosphate production and is implicated in intracellular Ca(2+) mobilization. Endocrinology (2011) 152:1691-701. doi:10.1210/en.2010-1353.
44. Cohen BD, Nechamen CA, Dias JA. Human follitropin receptor (FSHR) interacts with the adapter protein 14-3-3tau. Mol Cell Endocrinol (2004) 220:1-7. doi:10.1016/j.mce.2004.04.012.
45. Dias JA, Mahale SD, Nechamen CA, Davydenko O, Thomas RM, Ulloa-Aguirre A. Emerging roles for the FSH receptor adapter protein APPL1 and overlap of a putative 14-3-3t interaction domain with a canonical G-protein interaction site. Mol Cell Endocrinol (2010) 329:17-25. doi:10.1016/j.mce.2010.05.009.
46. Gershengorn MC, Osman R. Minireview: insights into G protein-coupled receptor function using molecular models. Endocrinology (2001) 142:2-10. doi:10.1210/endo.142.1.7919.
47. Timossi C, Maldonado D, Vizcaíno A, Lindau-Shepard B, Conn PM, Ulloa-Aguirre A. Structural determinants in the second intracellular loop of the human follicle-stimulating hormone receptor are involved in G(s) protein activation. Mol Cell Endocrinol (2002) 189:157-68. doi:10.1016/S0303-7207(01)00720-1.
48. Nakamura K, Krupnick JG, Benovic JL, Ascoli M. Signaling and phosphorylation-impaired mutants of the rat follitropin receptor reveal an activation- and phosphorylation-independent but arrestin dependent pathway for internalization. J Biol Chem (1998) 273:24346-54. doi:10.1074/jbc.273.38.24346.
49. Fernandez LM, Puett D. Evidence for an important functional role of intracellular loop II of the lutropin receptor. Mol Cell Endocrinol (1997) 128:161-9. doi:10.1016/S0303-7207(97)04035-5.
50. Grasso P, Leng N, Reichert LE Jr. A synthetic peptide corresponding to the third cytoplasmic loop (residues 533 to 555) of the testicular follicle-stimulating hormone receptor affects signal transduction in rat testis membranes and in intact cultured rat Sertoli cells. Mol Cell Endocrinol (1995) 110:35-41. doi:10.1016/0303-7207(95)91392-T.
51. Bhaskaran RS, Min L, Krishnamurthy H, Ascoli M. Studies with chimeras of the gonadotropin receptors reveal the importance of third intracellular loop threonines on the formation of the receptor/nonvisual arrestin complex. Biochemistry (2003) 42:13950-9. doi:10.1021/bi034907w.
52. Timossi C, Ortiz-Elizondo C, Pineda DB, Dias JA, Conn PM, Ulloa-Aguirre A. Functional significance of the BBXXB motif reversed present in the cytoplasmic domains of the human follicle-stimulating hormone receptor. Mol Cell Endocrinol (2004) 223:17-26. doi:10.1016/j.mce.2004.06.004.
53. Cohen BD, Bariteau JT, Magenis LM, Dias JA. Regulation of follitropin receptor cell surface residency by the ubiquitin-proteasome pathway. Endocrinology (2003) 144:4393-402. doi:10.1210/en.2002-0063.
54. Beau I, Touraine P, Meduri G, Gougeon A, Desroches A, Matuchansky C, et al. A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor. J Clin Invest (1998) 102:1352-9. doi:10.1172/JCI3795.
55. Gromoll J, Simoni M, Nieschlag E. An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man. J Clin Endocrinol Metab (1996) 81:1367-70. doi:10.1210/jcem.81.4.8636335.
56. Smits G, Olatunbosun O, Delbaere A, Pierson R, Vassart G, Costagliola S. Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor. N Engl J Med (2003) 349:760-6. doi:10.1056/NEJMoa030064.
57. Lin FT, Chen W, Shenoy S, Cong M, Exum ST, Lefkowitz RJ. Phosphorylation of beta-arrestin2 regulates its function in internalization of beta(2)-adrenergic receptors. Biochemistry (2002) 41:10692-9. doi:10.1021/bi025705n.
58. Dias JA, Nechamen CA, Atari R. Identifying protein interactions in gonadotropin action. Endocrine (2005) 26:241-7. doi:10.1385/ENDO:26:3:241.
59. Kluetzman KS, Thomas RM, Nechamen CA, Dias JA. Decreased degradation of internalized follicle-stimulating hormone caused by mutation of aspartic acid 6.30(550) in a protein kinase-CK2 consensus sequence in the third intracellular loop of human follicle-stimulating hormone receptor. Biol Reprod (2011) 84:1154-63. doi:10.1095/biolreprod.110.087965.
60. Duvernay MT, Zhou F, Wu G. A conserved motif for the transport of G protein-coupled receptors from the endoplasmic reticulum to the cell surface. J Biol Chem (2004) 279:30741-50. doi:10.1074/jbc.M313881200.
61. Menon KM, Clouser CL, Nair AK. Gonadotropin receptors: role of post-translational modifications and post-transcriptional regulation. Endocrine (2005) 26:249-57. doi:10.1385/ENDO:26:3:249.
62. Uribe A, Zariñán T, Pérez-Solis MA, Gutiérrez-Sagal R, Jardón-Valadez E, Piñeiro A, et al. Functional and structural roles of conserved cysteine residues in the carboxyl-terminal domain of the follicle-stimulating hormone receptor in human embryonic kidney 293 cells. Biol Reprod (2008) 78:869-82. doi:10.1095/biolreprod.107.063925.
63. Claus M, Neumann S, Kleinau G, Krause G, Paschke R. Structural determinants for G-protein activation and specificity in the third intracellular loop of the thyroid-stimulating hormone receptor. J Mol Med (Berl) (2006) 84:943-54. doi:10.1007/s00109-006-0087-8.
64. Kara E, Crépieux P, Gauthier C, Martinat N, Piketty V, Guillou F, et al. A phosphorylation cluster of five serine and threonine residues in the C-terminus of the follicle-stimulating hormone receptor is important for desensitization but not for beta-arrestin-mediated ERK activation. Mol Endocrinol (2006) 20:3014-26. doi:10.1210/me.2006-0098.
65. Thomas RM, Nechamen CA, Mazurkiewicz JE, Muda M, Palmer S, Dias JA. Follice-stimulating hormone receptor forms oligomers and shows evidence of carboxyl-terminal proteolytic processing. Endocrinology (2007) 148:987-95. doi:10.1210/en.2006-1672.
66. Mazurkiewicz JE, Herrick-Davis K, Barroso M, Ulloa-Aguirre A, Lindau-Shepard B, Thomas RM, et al. Single molecule analyses of fully functional fluorescent protein tagged follitropin receptor reveals homodimerization and specific heterodimerization with lutropin receptor. Biol Reprod (2015) 92:100. doi:10.1095/biolreprod.114.125781.
67. Zariñán T, Perez-Solís MA, Maya-Núñez G, Casas-González P, Conn PM, Dias JA, et al. Dominant negative effects of human follicle-stimulating hormone receptor expression-deficient mutants on wild-type receptor cell surface expression. Rescue of oligomerization-dependent defective receptor expression by using cognate decoys. Mol Cell Endocrinol (2010) 321:112-22. doi:10.1016/j.mce.2010.02.027.
68. Perez-Mayorga M, Gromoll J, Behre HM, Gassner C, Nieschlag E, Simoni M. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab (2000) 85:3365-9. doi:10.1210/jcem.85.9.6789.
69. Behre HM, Greb RR, Mempel A, Sonntag B, Kiesel L, Kaltwasser P. Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenet Genomics (2005) 15:451-6. doi:10.1097/01.fpc.0000167330.92786.5e.
70. Jun JK, Yoon JS, Ku SY, Choi YM, Hwang KR, Park SY, et al. Follicle-stimulating hormone receptor gene polymorphism and ovarian responses to controlled ovarian hyperstimulation for IVF-ET. J Hum Genet (2006) 51:665-70. doi:10.1007/s10038-006-0005-5.
71. Loutradis D, Patsoula E, Minas V, Koussidis GA, Antsaklis A, Michalas S, et al. FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programs. J Assist Reprod Genet (2006) 23:177-84. doi:10.1007/s10815-005-9015-z.
72. Wunsch A, Sonntag B, Simoni M. Polymorphism of the FSH receptor and ovarian response to FSH. Ann Endocrinol (Paris) (2007) 68:160-6. doi:10.1016/j.ando.2007.04.006.
73. Boudjenah R, Molina-Gomes D, Torre A, Bergere M, Bailly M, Boitrelle F, et al. Genetic polymorphisms influence the ovarian response to rFSH stimulation inpatients undergoing in vitro fertilization programs with ICSI. PLoS One (2012) 7:e38700. doi:10.1371/journal.pone.0038700.
74. Desai SS, Achrekar SK, Paranjape SR, Desai SK, Mangoli VS, Mahale SD. Association of allelic combinations of FSHR gene polymorphisms with ovarian response. Reprod Biomed Online (2013) 27:400-6. doi:10.1016/j.rbmo.2013.07.007.
75. Thompson MD, Hendy GN, Percy ME, Bichet DG, Cole DE. G protein-coupled receptor mutations and human genetic disease. Methods Mol Biol (2014) 1175:153-87. doi:10.1007/978-1-4939-0956-8_8.
76. Thompson MD, Cole DE, Capra V, Siminovitch KA, Rovati GE, Burnham WM, et al. Pharmacogenetics of the G protein-coupled receptors. Methods Mol Biol (2014) 1175:189-242. doi:10.1007/978-1-4939-0956-8_9.
77. Simoni M, Casarini L. Mechanisms in endocrinology: genetics of FSH action: a 2014-and-beyond view. Eur J Endocrinol (2014) 170:R91-107. doi:10.1530/EJE-13-0624.
78. Desai SS, Roy BS, Mahale SD. Mutations and polymorphisms in FSH receptor: functional implications in human reproduction. Reproduction (2013) 146:R235-48. doi:10.1530/REP-13-0351.
79. Siegel ET, Kim HG, Nishimoto HK, Layman LC. The molecular basis of impaired follicle-stimulating hormone action: evidence from human mutations and mouse models. Reprod Sci (2013) 20:211-33. doi:10.1177/1933719112461184.
80. Van Koppen CJ, Verbost PM, van de Lagemaat R, Karstens WJ, Loozen HJ, van Achterberg TA. Signaling of an allosteric, nanomolar potent, low molecular weight agonist for the follicle-stimulating hormone receptor. Biochem Pharmacol (2013) 85:1162-70. doi:10.1016/j.bcp.2013.02.001.
81. Sriraman V, Denis D, de Matos D, Yu H, Palmer S, Nataraja S. Investigation of a thiazolidinone derivative as an allosteric modulator of follicle stimulating hormone receptor: evidence for its ability to support follicular development and ovulation. Biochem Pharmacol (2014) 89:266-75. doi:10.1016/j.bcp.2014.02.023.
82. Janovick JA, Maya-Núñez G, Ulloa-Aguirre A, Huhtaniemi IT, Dias JA, Verbost P, et al. Increased plasma membrane expression of human follicle-stimulating hormone receptor by a small molecule thienopyr(im)idine. Mol Cell Endocrinol (2009) 298:84-8. doi:10.1016/j.mce.2008.09.015.